Peter J Andrulis, Jr

Title: Innovations in Antitumor Therapy by Peter J Andrulis, Jr.

Introduction

Peter J Andrulis, Jr. is a notable inventor based in Washington, DC, recognized for his contributions to the field of antitumor agents. He has been instrumental in developing bis-platinum complexes that serve as effective treatments against various tumors. With a total of 2 patents, his work has significantly impacted cancer therapy.

Latest Patents

Andrulis's latest patents focus on the use of bis-platinum complexes as antitumor agents. These complexes are characterized by a specific formula where A is a ligand with two pairs of platinum-coordinating acidic groups, which can be carboxylate, phenolate, sulfonate, or phosphonate groups. Each pair is capable of coordinating with a platinum ion to form a 5-10 membered chelate ring. The complexes also include a water-solubilizing group, making them readily soluble and effective in antitumor therapy against tumors that are susceptible to treatment with platinum complexes.

Career Highlights

Peter J Andrulis, Jr. is associated with Andrulis Research Corporation, where he continues to innovate in the field of cancer treatment. His research has led to advancements in the development of water-soluble antitumor agents, which are crucial for effective therapy.

Collaborations

One of his notable collaborators is Paul Steven Schwartz, with whom he has worked on various projects related to his patents and research.

Conclusion

Peter J Andrulis, Jr. has made significant strides in the development of bis-platinum complexes for antitumor therapy. His innovative work continues to influence the field of cancer treatment, showcasing the importance of research and development in medical science.